Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
M&A activity
confidence 95%
filed 2026-07-27
EX-99.1
SNDL announced completion of the acquisition of certain assets of Surterra Holdings, Inc. (Parallel), a U.S. vertically integrated cannabis operator with operations in Florida, Texas, and Massachusetts. The transaction was completed pursuant to a strict foreclosure agreement and provides SNDL, through its Sunstream joint venture, with indirect majority economic exposure (66.7% equity, 69.4% debt) to TransactionCo. The press release explicitly states this represents "a defining milestone in our strategy to become a leading vertically integrated North American cannabis company" and notes the company now supports a 249-store cannabis retail network. This is a material acquisition of operating assets generating approximately US$150 million in annualized revenue.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-07-27
Item 1.01
The Company entered into Amendment No. 4 to its Loan Agreement with Old National Bank on July 24, 2026, extending the maturity of its line of credit from July 24, 2026 to November 21, 2026. While this is technically an amendment to an existing credit facility rather than a new issuance, it represents a material modification to a direct financial obligation that extends the Company's access to credit. The extension of a maturing line of credit is a material financial event affecting the Company's liquidity and capital structure, warranting disclosure under Item 1.01.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-27
Item 2.02
This is a clear earnings release for Q2 2026 issued on July 24, 2026, disclosing net income of $5,704,000 (down 1.8% YoY), EPS of $1.00, and comprehensive financial results including balance sheet metrics, income statement details, and key ratios. The press release is attached as Exhibit 99 and filed under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-27
EX-99.1
QTREX announced a research collaboration with Northeastern University to develop quantum interconnect technologies, with a first option to commercialize jointly developed intellectual property. This is a strategic partnership and innovation initiative that expands the company's quantum connectivity platform and product pipeline. While not a discrete M&A transaction, material contract, or regulatory milestone fitting a named category, it represents a material operational and strategic development that would affect a reasonable investor's assessment of the company's technology roadmap and competitive positioning in quantum computing infrastructure.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-07-27
Item 4.01
This is a straightforward auditor change disclosure under Item 4.01. The Company's independent registered public accounting firm changed from YCM CPA INC. to DLEE Accountancy, Inc. on July 27, 2026. The filing explicitly states the engagement with YCM expired and the Audit Committee engaged DLEE as the new independent registered public accounting firm. Auditor changes are material events that affect investor assessment of financial reporting reliability.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-07-27
The 6-K discloses the appointment of Alan Bash as Interim Chief Executive Officer effective July 24, 2026, following the resignation of Ying Huang. While both a departure and appointment occur, the principal disclosed action is Bash's appointment to the CEO role, with detailed background on his qualifications and prior experience. The appointment of an interim CEO to a critical executive position is material to investors assessing company leadership and continuity.
View raw filing on EDGAR →
6-K
Legal Other
confidence 92%
filed 2026-07-27
Trip.com received an administrative penalty decision from China's SAMR on July 25, 2026, following an anti-monopoly investigation. The SAMR found violations of the Anti-Monopoly Law and imposed a fine of RMB 3.521 billion (US$518.9 million), representing 7.5% of the Company's 2025 China revenue, plus ordered refunds of RMB 122 million and confiscation of RMB 1.658 billion in gains. This is a material regulatory enforcement action with substantial financial consequences that would affect a reasonable investor's assessment of the registrant's legal and financial position.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-07-27
EX-99
HDFC Bank is exercising a call option to redeem US$1 billion in 3.7% Additional Tier 1 Notes on August 25, 2026. While this is technically a redemption (retirement) of existing debt rather than issuance of new debt, it represents a material modification of the bank's capital structure and direct financial obligations. The redemption of $1 billion in AT1 Notes—a key component of regulatory capital—is a significant financial event that would affect investor assessment of the bank's capital management and financial position.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-27
Item 1.01
Forte Biosciences entered into an Agreement and Plan of Merger with argenx BV on July 26, 2026, providing for acquisition of the Company at $77.00 per share in cash, representing approximately $2.2 billion in total equity value. The transaction consists of a tender offer followed by a merger under Delaware law, with Forte becoming a wholly owned subsidiary of argenx.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-07-27
C3is Inc. announced the pricing of an underwritten public offering of 11,535,000 units at $0.52 per unit, generating approximately $6.0 million in gross proceeds. Each unit includes one common share (or pre-funded warrant) and one Class F warrant, with the warrants featuring a zero cash exercise option that could double the number of shares issuable. This is a material dilutive equity issuance that would significantly affect a reasonable investor's assessment of ownership dilution and capital structure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 89%
filed 2026-07-27
Item 1.01
The Fund's subsidiary TNVA1 amended its Loan and Security Agreement with HSBC, extending the maturity date to June 9, 2028 and providing an additional $40.88 million loan, increasing total borrowings to $188.59 million. The Fund also reinstated a guarantee obligation of up to $47.15 million in connection with the amendment.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-27
Item 1.01
On July 21–23, 2026, the Company entered into four material definitive agreements establishing its operational and governance structure: an Advisory Agreement with ElmTree Funds (with tiered management fees of 1.25%–0.50% of NAV), an Amended and Restated Limited Partnership Agreement (with performance participation allocations of 5.0%–12.5% of Total Return), a Dealer Manager Agreement with HPS Securities for share distribution and shareholder servicing, and an Administration Agreement with HPS Investment Partners for administrative services.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-27
Item 5.02
Five new trustees were elected to the Board effective July 21, 2026 (Robert F. Cummings, Jr., Lisa Hess, James G. Koman, David Lehman, and Robert Van Dore), increasing board size from one to six members, with James G. Koman designated as Board chairperson.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-07-27
Item 8.01
The Company adopted a distribution reinvestment plan (DRIP) on July 21, 2026, whereby shareholders' cash distributions are automatically reinvested in additional common shares unless they elect otherwise.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-27
Item 8.01
Codexis completed a public offering of 16,666,667 shares of common stock at $1.50 per share, raising approximately $23.1 million in net proceeds. This is a material dilutive equity issuance disclosed under Item 8.01, representing a significant capital raise and shareholder dilution event that would affect a reasonable investor's assessment of the company's capitalization and ownership structure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-27
Item 2.02
Agilysys issued a press release on July 27, 2026 announcing fiscal 2027 first quarter results, including record revenue of $87.7M (14.3% growth), net income of $9.0M ($0.32 per diluted share), and raised full-year guidance for total revenue to $368M–$373M and subscription revenue growth to at least 32%. This is a standard quarterly earnings release disclosure under Item 2.02, with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-07-27
Item 8.01
Aptevo announced a new solid tumor strategy and filed a patent application for a proprietary Nectin-4 x PD-L1 dual-targeting backbone designed to strengthen its oncology pipeline and expand partnering opportunities. This is a strategic operational and scientific milestone—a platform innovation that supports multiple therapeutic approaches—rather than a specific financial, governance, or legal event. The filing strengthens IP protection and represents a material strategic pivot in the company's pipeline development approach, making it material to investors assessing the company's oncology strategy and future value creation.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-27
Item 2.03
Zeta Global closed a new $1.0 billion senior secured credit facility on July 24, 2026, comprised of $250 million in Term Loan A and a $750 million Revolving Credit Facility, which refinances existing debt and provides capital for M&A, share repurchases, and general corporate purposes. The facility reduces credit spreads and strengthens the company's liquidity and financial flexibility.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-27
EX-99.1
Baidu is convening an Extraordinary General Meeting of shareholders scheduled for August 26, 2026, to vote on six resolutions: (1) a general mandate to allot and issue Class A shares up to 20% of outstanding shares; (2) authorization to repurchase up to 10% of shares; (3) extension of the issuance mandate by repurchased shares; (4) approval and adoption of the 2026 Share Incentive Plan with a 10% scheme limit and 0.5% consultant sublimit; and (5) adoption of amended and restated Articles of Association. These governance matters, undertaken in preparation for the company's voluntary conversion from secondary to dual-primary listing status on the Hong Kong Stock Exchange, would materially affect capital structure, equity dilution, equity compensation, and corporate governance framework.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-27
Item 2.02
Rambus issued a press release on July 27, 2026 announcing Q2 2026 financial results, including record quarterly revenue of $207.4 million (exceeding guidance), GAAP diluted EPS of $0.61, and non-GAAP diluted EPS of $0.77 (exceeding non-GAAP guidance). The filing explicitly states this is Item 2.02 disclosure with the press release attached as Exhibit 99.1, which is the standard format for earnings releases.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-07-27
EX-99.1
This is a formal earnings press release announcing TFI International's Q2 2026 financial results. The document discloses second quarter operating income of $220.4 million (up 29%), net income of $136.2 million (up 39%), and diluted EPS of $1.65 (up 41%), along with six-month comparative results and segment performance. The release includes detailed financial tables, management commentary from the CEO, and forward guidance for Q3 2026 adjusted diluted EPS. This is a material event affecting investor assessment of the registrant's financial performance and position.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-27
Item 2.02
OPKO Health issued a press release on July 27, 2026 announcing operating and financial highlights for the quarter ended June 30, 2026, including consolidated total revenues of $163.5 million, operating loss of $7.0 million, and net loss of $8.4 million ($0.01 per share). The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings disclosures. The company also provided 2026 third quarter and full-year financial guidance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-27
Item 5.02
Nan (Richard) Hu was appointed as Chief Executive Officer, effective August 17, 2026, following a comprehensive board-led executive search conducted by Spencer Stuart. Xun (Kenneth) Li transitioned from Interim CEO to Chief Financial Officer.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-27
Item 5.07
At the July 23, 2026 Annual Meeting of Stockholders, all four proposals were approved: election of seven directors, ratification of BDO USA as independent auditor, advisory vote on named executive officer compensation, and frequency of future advisory votes on compensation.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-27
Item 5.02
Kymera Therapeutics appointed Terence Rooney, M.D., as Chief Medical Officer effective July 27, 2026, succeeding Jared Gollob who retired after eight years. Dr. Rooney will lead the company's clinical development strategy across its pipeline.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-07-27
Item 7.01
The Company announced that its Board of Directors has declared an initial quarterly cash dividend of $0.07 per share, payable on August 28, 2026, to shareholders of record as of August 14, 2026. This is a clear dividend declaration that would materially affect investor assessment of capital allocation and shareholder returns, particularly as the Company's first dividend initiation.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-07-27
Item 8.01
The filing announces that Silvercrest will host a teleconference on July 31, 2026, to discuss financial results for Q2 2026 ended June 30, 2026, with a news release to be issued before market open. This is a standard earnings announcement disclosure. Although the actual results are not yet disclosed in this 8-K (they will be released separately), the announcement of the earnings call and the imminent release of quarterly financial results constitutes an earnings_release event under the taxonomy.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-27
Item 2.02
Universal Health Realty Income Trust disclosed its second quarter 2026 earnings on July 27, 2026, reporting net income of $5.9 million ($.43 per diluted share) for Q2 2026 versus $4.5 million ($.32 per diluted share) for Q2 2025, along with six-month results and detailed financial statements. The press release, furnished as Exhibit 99.1, is a standard earnings announcement with consolidated statements of income, non-GAAP supplemental schedules, and management discussion of operating performance, making this a clear earnings_release event material to investors.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-07-27
Item 5.03
Goldman Sachs issued Series AA Preferred Stock and filed a Certificate of Designations establishing its terms. The issuance materially restricts common shareholders' rights, as the company cannot declare or pay dividends on, or repurchase, common stock if it fails to pay dividends on the preferred stock.
View raw filing on EDGAR →
8-K
M&A activity
confidence 94%
filed 2026-07-27
Item 1.01
Talos Energy entered into a definitive farm-in agreement to acquire a 50% working interest in Block 29 offshore Mexico from Repsol, containing over 200 MMBoe of gross recoverable resource. The transaction includes contingent payments of $30 million at FID and up to $20 million in cash carry commitments, and was accompanied by an amendment to the company's Credit Agreement to increase debt capacity and leverage ratios to finance the Block 29 Project.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-27
Item 2.02
The Item 2.02 disclosure announces unaudited consolidated financial results for the three and six months ended June 30, 2026, with a press release attached as Exhibit 99.1. The press release reports Q2 2026 net income of $7.2 million ($0.39 per share) versus Q1 2026 net income of $6.0 million ($0.32 per share), along with detailed financial highlights, balance sheet data, revenue analysis, and asset quality metrics. This is a standard earnings release disclosure material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-27
Item 2.02
Nucor Corporation issued a news release reporting its financial results for the quarter ended July 4, 2026, with net earnings of $1.16 billion ($5.04 per diluted share) and net sales of $10.40 billion, along with segment-by-segment financial analysis and forward guidance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-27
Item 2.02
This is a straightforward earnings release disclosing quarterly and year-to-date financial results for the period ended June 30, 2026. The press release announces net income of $11.8 million for Q2 2026 (a quarterly record), earnings per share of $0.86, and comprehensive financial metrics including net interest margin, efficiency ratio, and deposit growth. The filing is made under Item 2.02 (Results of Operation and Financial Condition) with the press release attached as Exhibit 99, which is the standard format for earnings disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-27
Item 2.02
Peapack-Gladstone Financial Corporation disclosed second quarter 2026 financial results, reporting net income of $15.8 million ($0.85 per diluted share), total revenue of $86.1 million (23% year-over-year growth), and other key metrics including net interest income, loan growth, and deposit increases.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-27
Item 2.02
Brown & Brown issued a press release on July 27, 2026 announcing its second quarter 2026 financial results, including total revenues of $1.7 billion (up 30.4%), net income of $288 million (up 24.7%), and diluted EPS of $0.84 (up 7.7%). The filing explicitly states under Item 2.02 that the company "issued a press release announcing its results of operations for the second quarter ended June 30, 2026," with the press release furnished as Exhibit 99.1. This is a standard quarterly earnings disclosure material to investors.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-27
EX-99.1
This is a press release announcing preliminary H1 2026 financial results, with expected revenue of approximately $127 million (nearly 20x H1 2025 revenue of $6.32 million) and reaffirmed full-year 2026 guidance of approximately $360 million. The disclosure explicitly states "Based on preliminary, unaudited management accounts" and announces "a historic first-half operating milestone," making it a classic earnings release announcing interim financial results to the market.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-27
Item 3.02
Apollo Infrastructure Company LLC issued and sold approximately $42.3 million in unregistered equity securities across multiple share classes (Series I and Series II A-II, E, F-I, and I Shares) to third-party investors as of July 1, 2026, under Section 4(a)(2) and Regulations D and S exemptions.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-27
Item 1.01
Somnigroup amended its senior secured credit facilities (Amendment No. 5 to the Credit Agreement), establishing a new $1.2 billion Term A Loan and $510 million incremental revolving commitment, extending maturity to July 27, 2031. The refinancing reduces annual interest expense by approximately $5 million and enhances financial flexibility through $700 million of incremental liquidity.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-07-27
EX-99.1
The press release announces a concurrent registered direct offering of 1,281,646 ADSs (384.5 million ordinary shares) at US$3.16 per ADS raising approximately US$4.1 million, plus unregistered warrants and an Australian private placement and share purchase plan raising up to A$12.7 million (US$8.9 million). This is a material dilutive equity issuance totaling approximately US$12.9 million in gross proceeds, typical of capital-raising activity by clinical-stage biopharmaceutical companies and clearly material to investors assessing ownership dilution and cash position.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-27
EX-99.2
Wetour Robotics announced the Orchestra platform, a portable AI hub and operating system for wearable robotics powered by NVIDIA Jetson, featuring core modules (Vision-Link and Conductor) and an open architecture designed to enable third-party adoption. This represents a significant product development and strategic technology initiative affecting the company's competitive positioning in the Physical AI and wearable robotics market.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-27
EX-99.1
ParaZero announced a new integrated Counter-UAS capability combining its DefendAir Net Pod with Axon Vision's ForceField Edge AI system, including a successful demonstration and a non-binding MOU for continued integration and potential commercialization. This is a material strategic partnership and product integration announcement that expands ParaZero's market pathways and demonstrates operational validation, but it does not constitute a discrete M&A transaction, material contract award, or other specifically-named event type—it is a strategic operational and commercial development.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-07-27
The 6-K discloses receipt of a shareholder demand from J.B.D Innovation Ltd. and Victor Tshuva & Co. (holding ~24.8% of voting rights) to convene a special general meeting seeking to amend the articles of association, remove four of five current directors, and elect four nominees designated by the proposing shareholders. This is a governance event involving potential board composition change and shareholder activism, not fitting the specific categories of exec_departure or exec_appointment (which address individual personnel moves), but clearly material to investors as it signals potential control contest and strategic direction uncertainty.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 92%
filed 2026-07-27
The filing discloses that Maison Solutions regained compliance with Nasdaq Listing Rule 5620(a) after receiving a non-compliance notice on May 6, 2026, for failing to hold an annual meeting within one year of fiscal year-end. The company held its annual meeting on July 22, 2026, and Nasdaq confirmed on July 24, 2026, that compliance was restored and "the matter is now closed." This is a delisting-risk event because it documents the company's prior non-compliance with a continued listing requirement and its subsequent remediation, which is material to investors assessing listing status.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-27
The 6-K discloses the results of a Special General Meeting of Shareholders held on July 27, 2026, where shareholders voted upon and approved the sole agenda item after an initial adjournment due to lack of quorum. This is a direct disclosure of shareholder vote results, matching the definition of Item 5.07 (shareholder_vote_results). The materiality is high because shareholder votes on special matters are typically material to investors' assessment of corporate governance and strategic decisions.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-27
EX-99.1
This is a press release announcing Aurelion's unaudited financial results for the third fiscal quarter ended June 30, 2026. The exhibit discloses quarterly operating loss of $24.4 million, net loss of $25.1 million, NAV of $91.9 million, and condensed consolidated financial statements (income statement and balance sheet). The disclosure of quarterly financial results in press-release format is a classic earnings_release event, material to investors assessing the registrant's financial performance and position.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-27
Item 2.02
Commercial Bancgroup disclosed Q2 2026 quarterly financial results via press release dated July 27, 2026, reporting net income of $10.2 million ($0.75 per share) with comprehensive financial highlights including balance sheet, performance ratios, and asset quality metrics.
View raw filing on EDGAR →
6-K
Governance Other
confidence 92%
filed 2026-07-27
EX-99.1
Top Wealth Group Holding Ltd furnished a proxy statement and notice of an extraordinary general meeting seeking shareholder approval for material governance and capital structure changes: a 25-fold increase in authorized share capital from US$19.8M to US$495M, amendments to the memorandum and articles of association including variation of Class B share rights and arbitration provisions, and authorization for share consolidation at ratios ranging from 5-for-1 to 250-for-1.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-27
Item 1.01
HeartSciences entered into Amendment No. 1 to an Agreement and Plan of Merger with Fortitude Mining Holdings, Inc. on July 27, 2026, amending the original merger agreement dated June 23, 2026. The filing discloses a material acquisition/merger transaction contemplated by the Amended Merger Agreement, which will require shareholder approval via proxy statement. This is a clear M&A activity event under Item 1.01.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-07-27
Oriental Culture Holding LTD entered into a Share Transfer Agreement on July 27, 2026, to dispose of 100% equity interest of its wholly owned subsidiary China International Assets Equity of Artworks Exchange Limited to Spring Harvest Holdings Ltd. for HK$1,000,000. The filing explicitly states this disposal is "a significant step in implementing the Company's new development strategy" and represents a material shift from the Company's principal business as an online collectibles and artwork e-commerce provider to a service-oriented business. This constitutes a material disposition triggering Item 1.02 disclosure.
View raw filing on EDGAR →
6-K
Governance Other
confidence 65%
filed 2026-07-27
EX-99.1
ICZOOM Group is soliciting shareholder votes on two share consolidation proposals at an Extraordinary General Meeting scheduled for August 14, 2026: a mandatory 1-for-5 consolidation of Class A and Class B shares, and authorization for a discretionary further consolidation at a ratio between 1-for-2 and 1-for-10 to be determined by the board by February 10, 2027.
View raw filing on EDGAR →